Krystal Biotech, Inc. (KRYS)
USD 168.94
(-5.16%)
USD 168.94
(-5.16%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -350.23 Million USD | -128.96% |
| 2022 | -152.96 Million USD | 54.09% |
| 2021 | -333.22 Million USD | -29.8% |
| 2020 | -256.72 Million USD | -39.33% |
| 2019 | -184.25 Million USD | -77.73% |
| 2018 | -103.67 Million USD | -109.05% |
| 2017 | -49.59 Million USD | -61888.75% |
| 2016 | -80 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -338.09 Million USD | 3.71% |
| 2024 Q2 | -372.67 Million USD | -10.23% |
| 2023 FY | -350.23 Million USD | -128.96% |
| 2023 Q2 | -364.92 Million USD | -36.5% |
| 2023 Q3 | -350.23 Million USD | 4.02% |
| 2023 Q1 | -267.33 Million USD | -102.54% |
| 2023 Q4 | -351.11 Million USD | -0.25% |
| 2022 Q2 | -177.28 Million USD | 15.41% |
| 2022 Q4 | -131.98 Million USD | 13.72% |
| 2022 FY | -152.96 Million USD | 54.09% |
| 2022 Q1 | -209.58 Million USD | 19.39% |
| 2022 Q3 | -152.96 Million USD | 13.72% |
| 2021 Q1 | -321.69 Million USD | 19.23% |
| 2021 FY | -333.22 Million USD | -29.8% |
| 2021 Q4 | -260 Million USD | 21.97% |
| 2021 Q3 | -333.22 Million USD | -19.64% |
| 2021 Q2 | -278.51 Million USD | 13.42% |
| 2020 Q2 | -279.27 Million USD | 3.21% |
| 2020 Q1 | -288.52 Million USD | -62.99% |
| 2020 FY | -256.72 Million USD | -39.33% |
| 2020 Q4 | -398.3 Million USD | -55.15% |
| 2020 Q3 | -256.72 Million USD | 8.07% |
| 2019 FY | -184.25 Million USD | -77.73% |
| 2019 Q4 | -177.01 Million USD | 3.93% |
| 2019 Q3 | -184.25 Million USD | 3.78% |
| 2019 Q1 | -183.22 Million USD | -93.64% |
| 2019 Q2 | -191.48 Million USD | -4.51% |
| 2018 Q1 | -41.81 Million USD | 11.47% |
| 2018 Q3 | -103.67 Million USD | -122.15% |
| 2018 Q2 | -46.66 Million USD | -11.61% |
| 2018 FY | -103.67 Million USD | -109.05% |
| 2018 Q4 | -94.61 Million USD | 8.73% |
| 2017 Q2 | -52.57 Million USD | -1394.31% |
| 2017 Q4 | -47.22 Million USD | 4.76% |
| 2017 FY | -49.59 Million USD | -61888.75% |
| 2017 Q1 | -3.51 Million USD | 0.0% |
| 2017 Q3 | -49.59 Million USD | 5.67% |
| 2016 FY | -80 Thousand USD | 0.0% |
| 2016 Q3 | -80 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -526.089% |
| Alkermes plc | -166.73 Million USD | -110.049% |
| Agenus Inc. | 274.13 Million USD | 227.759% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 118.73% |
| Aptorum Group Limited | 1.35 Million USD | 25908.558% |
| Ardelyx, Inc. | 34.51 Million USD | 1114.818% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 8283.037% |
| Bicycle Therapeutics plc | -481.46 Million USD | 27.257% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1068.487% |
| ChromaDex Corporation | -24.04 Million USD | -1356.396% |
| Chimerix, Inc. | -25.51 Million USD | -1272.552% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 5126.266% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1379.216% |
| CRISPR Therapeutics AG | -150.84 Million USD | -132.181% |
| Precision BioSciences, Inc. | -85.41 Million USD | -310.062% |
| Dyadic International, Inc. | -6.37 Million USD | -5391.197% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -2098.167% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4669.263% |
| Lantern Pharma Inc. | -21.7 Million USD | -1513.738% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -216.848% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -3999.576% |
| Incyte Corporation | -3.17 Billion USD | 88.969% |
| IO Biotech, Inc. | -140.69 Million USD | -148.924% |
| Jaguar Health, Inc. | 29.39 Million USD | 1291.637% |
| Novavax, Inc. | -298.29 Million USD | -17.412% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 6662.376% |
| Opthea Limited | 28.15 Million USD | 1343.842% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1986.092% |
| ContextLogic Inc. | -232 Million USD | -50.963% |
| MiMedx Group, Inc. | -33.9 Million USD | -933.108% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3535.351% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -15015.663% |
| NextCure, Inc. | -6.47 Million USD | -5307.349% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -593.519% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -5390.422% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2979.44% |
| Vaxcyte, Inc. | -368.22 Million USD | 4.886% |
| PDS Biotechnology Corporation | -32.7 Million USD | -970.761% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 2127.052% |
| Pharming Group N.V. | 109.8 Million USD | 418.963% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1913.302% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -99.871% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1791.127% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1791.127% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -4832.873% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -5876.689% |
| Acelyrin, Inc. | -216.9 Million USD | -61.47% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -6142.733% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -20215.197% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1110.077% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -5048.229% |
| Senti Biosciences, Inc. | 1.74 Million USD | 20228.391% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -89.719% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -352.201% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -5677.532% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 351144.915% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 55869.745% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -199.228% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -108.184% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 415.896% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -4510.769% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -171.26% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 5179.832% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -44.508% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1900.218% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -10.588% |
| MEI Pharma, Inc. | -3.7 Million USD | -9353.009% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2899.409% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 316.539% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1360.152% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4669.263% |
| Precigen, Inc. | -481 Thousand USD | -72713.722% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2587.281% |
| AlloVir, Inc. | -62.69 Million USD | -458.658% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -529.759% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 667.953% |
| ImmuCell Corporation | 10.99 Million USD | 3286.68% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -127.209% |
| Onconetix, Inc. | 5.33 Million USD | 6669.223% |
| PureTech Health plc | -167.19 Million USD | -109.474% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1049.816% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1731.959% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -7034.528% |
| Seer, Inc. | -4.24 Million USD | -8160.236% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1357.062% |
| Innoviva, Inc. | 255.56 Million USD | 237.044% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -526.94% |
| ESSA Pharma Inc. | -33.62 Million USD | -941.694% |
| GlycoMimetics, Inc. | -40.98 Million USD | -754.554% |
| GT Biopharma, Inc. | -1.02 Million USD | -34203.036% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -416.699% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 671.745% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -161.215% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2427.67% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -1113.058% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -464808.276% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1034.839% |
| Aptose Biosciences Inc. | -8.19 Million USD | -4173.827% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -11093.096% |
| Soligenix, Inc. | -4.95 Million USD | -6973.152% |
| Century Therapeutics, Inc. | 847 Thousand USD | 41449.941% |
| Kura Oncology, Inc. | -20.11 Million USD | -1640.899% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -755.774% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -4070.445% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 19325.721% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -10855.083% |
| Autolus Therapeutics plc | -186.59 Million USD | -87.693% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -610.356% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -26.991% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1122.044% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 313.079% |
| GRI Bio, Inc. | -1.79 Million USD | -19422.52% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3798.833% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -953.114% |
| IGM Biosciences, Inc. | -72.6 Million USD | -382.376% |
| INmune Bio, Inc. | -25.41 Million USD | -1278.277% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 332.018% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -591.356% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2055.369% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -12040.138% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1021.305% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -750.392% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1198.429% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 192.667% |
| Verastem, Inc. | -37.27 Million USD | -839.519% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3760.179% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -575.319% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -2214.067% |
| Histogen Inc. | -7.48 Million USD | -4577.895% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1520.942% |
| Surrozen, Inc. | -32.66 Million USD | -972.232% |
| Organovo Holdings, Inc. | -1.5 Million USD | -23140.478% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8231.985% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1947.205% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 13488.15% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 8527.19% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -4078.83% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -706.211% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -2302.671% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -10.558% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -48404.834% |
| Apollomics, Inc. | -27.39 Million USD | -1178.46% |
| Amarin Corporation plc | -191.04 Million USD | -83.33% |
| Mesoblast Limited | 55.96 Million USD | 725.831% |
| Turnstone Biologics Corp. | -14.58 Million USD | -2301.495% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1284.762% |
| Synaptogenix, Inc. | -28.66 Million USD | -1121.967% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -37318.163% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 818.694% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -40526.2% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -4720.123% |
| Exelixis, Inc. | -73.05 Million USD | -379.444% |
| Better Therapeutics, Inc. | -860 Thousand USD | -40624.884% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1358.518% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -45.102% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 47681.875% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -4608.627% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 28029.346% |
| Gritstone bio, Inc. | 39.49 Million USD | 986.893% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -316.445% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -13206.055% |
| Avid Bioservices, Inc. | 169.72 Million USD | 306.35% |
| Insmed Incorporated | 721.62 Million USD | 148.534% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3731.248% |
| MediWound Ltd. | -5.32 Million USD | -6480.872% |
| OmniAb, Inc. | 9.2 Million USD | 3905.65% |
| Alector, Inc. | -35.63 Million USD | -882.782% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 507.386% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -7007.021% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2745.472% |
| Zai Lab Limited | -775 Million USD | 54.809% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 202.842% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1527.103% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -324.629% |
| Immunic, Inc. | -45.34 Million USD | -672.461% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -81.266% |
| Veracyte, Inc. | -203.82 Million USD | -71.832% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 154.87% |
| FibroGen, Inc. | 56.76 Million USD | 716.968% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4033.004% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -12288.534% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -16816.673% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 107.63% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -10382.909% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -111.03% |
| TG Therapeutics, Inc. | 17.86 Million USD | 2060.777% |
| Galecto, Inc. | -21.21 Million USD | -1550.801% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1372.499% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 122.316% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1331.162% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2943.66% |
| XBiotech Inc. | -200.02 Million USD | -75.097% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -316.445% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 7834.85% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -893.205% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -353.565% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 6254.173% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -105.518% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -279.148% |
| Vaxxinity, Inc. | 10.13 Million USD | 3556.711% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 147.569% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -3152.68% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -431.012% |
| NexImmune, Inc. | -3.13 Million USD | -11076.576% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -10043.851% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -2217.673% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1192.376% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3801.871% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -281043.087% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -763.241% |
| Ainos, Inc. | 4.07 Million USD | 8688.528% |
| Pluri Inc. | 22.82 Million USD | 1634.163% |
| Prothena Corporation plc | -608.34 Million USD | 42.429% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -194.919% |
| Celularity Inc. | 65.19 Million USD | 637.251% |
| Rallybio Corporation | -24.1 Million USD | -1353.133% |
| Cue Biopharma, Inc. | -33.81 Million USD | -935.613% |
| MeiraGTx Holdings plc | -40.3 Million USD | -769.024% |
| Omeros Corporation | 331.17 Million USD | 205.755% |
| Humacyte, Inc. | -22.48 Million USD | -1457.565% |
| Immunocore Holdings plc | -358.59 Million USD | 2.331% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1325.164% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1033.407% |
| Blueprint Medicines Corporation | 702.83 Million USD | 149.832% |
| CalciMedica, Inc. | -5.53 Million USD | -6233.345% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -86.077% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -3328.96% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -774.776% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -953.24% |
| Pulmatrix, Inc. | -10.41 Million USD | -3262.139% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -5759.696% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -818.237% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -214.388% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -484.269% |
| Cytokinetics, Incorporated | 642.37 Million USD | 154.522% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -5914.666% |
| Nutriband Inc. | -251.65 Thousand USD | -139071.174% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -926.507% |
| Vor Biopharma Inc. | 4.3 Million USD | 8244.977% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 94.198% |
| Evogene Ltd. | -19.63 Million USD | -1683.814% |
| ProKidney Corp. | -56.23 Million USD | -522.793% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -619.58% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3691.566% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 125.679% |
| CorMedix Inc. | -43.05 Million USD | -713.504% |
| BioLineRx Ltd. | 7.33 Million USD | 4874.182% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1175.201% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 858.953% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1126.395% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 15801.836% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1435.037% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 2074.818% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -366.518% |
| MediciNova, Inc. | -50.78 Million USD | -589.661% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -344.431% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1556841.547% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5327.806% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -75.274% |
| Biomea Fusion, Inc. | -166.57 Million USD | -110.262% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -95.689% |
| Mereo BioPharma Group plc | -51.46 Million USD | -580.476% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -269.274% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -19.225% |
| Absci Corporation | -72.59 Million USD | -382.429% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7770.477% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -49.394% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -271.755% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -265.986% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -796.358% |
| Allakos Inc. | -24.97 Million USD | -1302.338% |
| Imunon, Inc. | -4.21 Million USD | -8211.493% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -2275.756% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -158.666% |
| BioAtla, Inc. | -109.01 Million USD | -221.283% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 47681.875% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -37198.616% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 3026.91% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1551.813% |
| XOMA Corporation | -29 Million USD | -1107.703% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -2014.94% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3784.583% |
| aTyr Pharma, Inc. | -7.44 Million USD | -4601.759% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -181.005% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -68.249% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -328.269% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -277.558% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -40663.562% |
| Akari Therapeutics, Plc | -3.84 Million USD | -9008.817% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 21680.884% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 125.363% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -29377.627% |
| UroGen Pharma Ltd. | 4.39 Million USD | 8076.179% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 408.628% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 486792.978% |
| Orgenesis Inc. | 21.78 Million USD | 1707.758% |
| Entera Bio Ltd. | -10.62 Million USD | -3195.08% |
| GH Research PLC | -78.07 Million USD | -348.575% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1471.402% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1213.755% |
| Xencor, Inc. | 29.64 Million USD | 1281.467% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -17680.072% |
| Replimune Group, Inc. | 1.41 Million USD | 24904.108% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -142906.354% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -177.047% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -29377.627% |
| Portage Biotech Inc. | -4.98 Million USD | -6931.399% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1556841.547% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -429.678% |
| OncoCyte Corporation | -6.56 Million USD | -5236.492% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 39127.07% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -7587.916% |
| Purple Biotech Ltd. | -14.13 Million USD | -2377.253% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1374.297% |
| scPharmaceuticals Inc. | -6.54 Million USD | -5251.169% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1998.194% |
| HilleVax, Inc. | -165.48 Million USD | -111.641% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -13699.606% |
| Tharimmune, Inc. | -10.93 Million USD | -3102.768% |
| Genprex, Inc. | -6.73 Million USD | -5098.179% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 5.036% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -295.924% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -24898.858% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -10458.93% |
| OKYO Pharma Limited | -826.84 Thousand USD | -42257.725% |
| Savara Inc. | 153 Thousand USD | 229011.112% |
| Curis, Inc. | -23.88 Million USD | -1366.212% |
| Daré Bioscience, Inc. | -5.15 Million USD | -6690.23% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -45032.55% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -5541.656% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 29655.612% |
| BeiGene, Ltd. | -2.25 Billion USD | 84.455% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2938.546% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 42.415% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -88.718% |
| Erasca, Inc. | -37.21 Million USD | -841.084% |
| bluebird bio, Inc. | 108.57 Million USD | 422.585% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -27094.34% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 192.472% |
| DBV Technologies S.A. | -126.98 Million USD | -175.805% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -27094.34% |
| Moderna, Inc. | -2.9 Billion USD | 87.952% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -3283.25% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -3122.617% |
| Molecular Templates, Inc. | 707 Thousand USD | 49638.048% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -1016.426% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 201.046% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -326.792% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -281.81% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -985.257% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -918.833% |
| MacroGenics, Inc. | -66.98 Million USD | -422.854% |
| RenovoRx, Inc. | -1.17 Million USD | -29757.971% |
| Adicet Bio, Inc. | -138.78 Million USD | -152.354% |
| Prime Medicine, Inc. | -27.94 Million USD | -1153.477% |
| Aditxt, Inc. | 18.12 Million USD | 2032.764% |
| Adagene Inc. | -87.62 Million USD | -299.686% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8308.116% |
| Quantum-Si incorporated | -118.55 Million USD | -195.414% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1072.737% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -4585.914% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -621.998% |
| SciSparc Ltd. | -2.06 Million USD | -16860.484% |
| Vericel Corporation | 1.27 Million USD | 27526.312% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2820.637% |
| Minerva Neurosciences, Inc. | 41 Million USD | 954.141% |
| Generation Bio Co. | 31.44 Million USD | 1213.692% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -99.718% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1032.6% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 400.39% |
| Invivyd, Inc. | -198.47 Million USD | -76.462% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -287.985% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -14507.153% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -394.751% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -5031.634% |
| 2seventy bio, Inc. | 181.71 Million USD | 292.738% |
| ADMA Biologics, Inc. | 90.06 Million USD | 488.864% |
| Clene Inc. | 3.34 Million USD | 10586.048% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3756.055% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1528.162% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5327.806% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -1.776% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1247.07% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 297.131% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -8459.899% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 7101.879% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -6623.632% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -168.782% |
| Evaxion Biotech A/S | 5.28 Million USD | 6724.633% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -211.131% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -166.798% |
| Trevena, Inc. | 2.25 Million USD | 15610.806% |
| Surrozen, Inc. | -32.66 Million USD | -972.232% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -579.934% |
| Cingulate Inc. | 3.08 Million USD | 11461.337% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -11824.889% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 4973.16% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3669.513% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -341.529% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -166.435% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -231.843% |
| Clearmind Medicine Inc. | -3.94 Million USD | -8783.242% |
| Kronos Bio, Inc. | -36.05 Million USD | -871.415% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3822.33% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 24119.444% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -545.521% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2529.413% |
| ImmunityBio, Inc. | 618.22 Million USD | 156.652% |
| Korro Bio, Inc. | -132.94 Million USD | -163.447% |
| Kineta, Inc. | -4.54 Million USD | -7612.706% |
| BioVie Inc. | -17.73 Million USD | -1875.113% |
| Codexis, Inc. | -43.27 Million USD | -709.397% |
| Celularity Inc. | 65.19 Million USD | 637.251% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -10951.878% |
| Celcuity Inc. | 6.78 Million USD | 5263.021% |
| Virax Biolabs Group Limited | -3.36 Million USD | -10308.316% |
| Cibus, Inc. | -8.07 Million USD | -4235.652% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -8181.721% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 7763.764% |
| IN8bio, Inc. | -16.38 Million USD | -2037.007% |
| Kodiak Sciences Inc. | -103.87 Million USD | -237.169% |
| Annexon, Inc. | -193.75 Million USD | -80.761% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 972972.225% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1901.452% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -9869.656% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 133.22% |
| Eyenovia, Inc. | 1.25 Million USD | 27925.013% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1401.743% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -10699.692% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -953.43% |
| Arcellx, Inc. | -296.95 Million USD | -17.941% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1695.519% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -494.877% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1589.748% |
| Moolec Science SA | 117.61 Thousand USD | 297877.514% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -812.091% |
| Geron Corporation | 14.76 Million USD | 2472.698% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -823.662% |
| Royalty Pharma plc | 5.65 Billion USD | 106.19% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -147.653% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -4910.914% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -6430.733% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -148.868% |
| Humacyte, Inc. | -22.48 Million USD | -1457.565% |
| Structure Therapeutics Inc. | -124.33 Million USD | -181.677% |
| 89bio, Inc. | -289.05 Million USD | -21.166% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1287.505% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -19542.961% |
| Genelux Corporation | -6.89 Million USD | -4976.591% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1027.641% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 518.945% |
| Notable Labs, Ltd. | -9.77 Million USD | -3482.59% |
| Liquidia Corporation | -80.17 Million USD | -336.831% |
| Mustang Bio, Inc. | -3.73 Million USD | -9274.572% |
| Immunovant, Inc. | -635.22 Million USD | 44.865% |
| Quantum-Si incorporated | -118.55 Million USD | -195.414% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1894.045% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -8353.633% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 4463.199% |
| Acasti Pharma Inc. | -23 Million USD | -1422.426% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -10301.253% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2055.369% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -154.272% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -11138.553% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1475.36% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1786.122% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -106.899% |
| PepGen Inc. | -60.67 Million USD | -477.277% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1424.347% |
| United Therapeutics Corporation | -507.7 Million USD | 31.016% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1731.193% |
| Solid Biosciences Inc. | -47.75 Million USD | -633.474% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -40526.2% |
| Immuneering Corporation | -54.94 Million USD | -537.451% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8231.985% |
| Silo Pharma, Inc. | -3.52 Million USD | -9837.667% |
| Belite Bio, Inc | -87.27 Million USD | -301.318% |
| XOMA Corporation | -29 Million USD | -1107.703% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -395.402% |
| Bionomics Limited | 227 Million USD | 254.281% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -201.194% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -13726.846% |
| uniQure N.V. | -102.95 Million USD | -240.195% |
| Cassava Sciences, Inc. | -121.13 Million USD | -189.125% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8308.116% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 955.251% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2828.133% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -11219.049% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 330509.435% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -10699.692% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4033.004% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -4622.681% |
| Altimmune, Inc. | -134.48 Million USD | -160.422% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 276.828% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -13726.846% |
| Compugen Ltd. | -12.9 Million USD | -2614.151% |
| Peak Bio, Inc. | 10.34 Million USD | 3487.124% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -123657.598% |
| Benitec Biopharma Inc. | -50.58 Million USD | -592.408% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -235.673% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1882.815% |
| Zura Bio Limited | -99.8 Million USD | -250.915% |
| PolyPid Ltd. | 6.17 Million USD | 5776.402% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 572.523% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1882.815% |
| Instil Bio, Inc. | 75.35 Million USD | 564.76% |
| argenx SE | -2.02 Billion USD | 82.737% |
| Immunome, Inc. | -97.02 Million USD | -260.958% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1456.942% |
| Verona Pharma plc | -220.44 Million USD | -58.877% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -388.179% |
| Shattuck Labs, Inc. | -121.42 Million USD | -188.439% |
| CervoMed Inc. | -7.79 Million USD | -4394.302% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -88.806% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -7909.01% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -165.852% |
| Moolec Science SA | 117.61 Thousand USD | 297877.514% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -15207.584% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 2302.954% |
| AnaptysBio, Inc. | -18.15 Million USD | -1829.558% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1829.664% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -397.626% |
| NeurAxis, Inc. | 145.7 Thousand USD | 240480.234% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 3218.18% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1129.193% |
| Achilles Therapeutics plc | -126.92 Million USD | -175.94% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -388.179% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -53311.313% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1585.939% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 24119.444% |
| Nutriband Inc. | -251.65 Thousand USD | -139071.174% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2559.13% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -4607.446% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 202.95% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1575.601% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 21.73% |
| Palisade Bio, Inc. | -12.06 Million USD | -2803.374% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -149.613% |
| Beam Therapeutics Inc. | -262.72 Million USD | -33.31% |
| Neurogene Inc. | -131.95 Million USD | -165.419% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1705.4% |
| AEON Biopharma, Inc. | -4.88 Million USD | -7076.926% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 7.147% |
| Sesen Bio, Inc. | -112.55 Million USD | -211.173% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -250.725% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -14817.584% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -797.438% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -320.54% |
| Athira Pharma, Inc. | -88.99 Million USD | -293.526% |
| Vaccinex, Inc. | -1.28 Million USD | -27092.081% |
| HCW Biologics Inc. | 2.85 Million USD | 12360.193% |
| XOMA Corporation | -29 Million USD | -1107.703% |
| Nektar Therapeutics | 210.24 Million USD | 266.588% |
| Arvinas, Inc. | -313.8 Million USD | -11.611% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 21680.884% |
| Merus N.V. | -192.88 Million USD | -81.578% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 683.869% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -4948.054% |
| Rezolute, Inc. | -68.16 Million USD | -413.781% |
| Clene Inc. | 3.34 Million USD | 10586.048% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2555.904% |
| BeyondSpring Inc. | -13.75 Million USD | -2446.23% |
| Synlogic, Inc. | -6.68 Million USD | -5139.102% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 30984.833% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -4042.33% |
| Peak Bio, Inc. | 10.34 Million USD | 3487.124% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -324.938% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 382.162% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -107.244% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -10993.381% |
| MannKind Corporation | 143.89 Million USD | 343.389% |
| Ikena Oncology, Inc. | -109.15 Million USD | -220.856% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -4525.994% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -958.109% |
| Gossamer Bio, Inc. | 180.35 Million USD | 294.191% |
| CohBar, Inc. | -5.93 Million USD | -5805.41% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -1077.336% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7770.477% |
| Legend Biotech Corporation | -949.39 Million USD | 63.11% |
| Mural Oncology plc | -255.84 Million USD | -36.894% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1187.177% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -7334.953% |
| Disc Medicine, Inc. | -358.28 Million USD | 2.246% |
| Champions Oncology, Inc. | 4.81 Million USD | 7378.346% |
| REGENXBIO Inc. | 54.76 Million USD | 739.487% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -130143.542% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -131.906% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3786.305% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -334.086% |
| Vaxart, Inc. | -8.24 Million USD | -4149.897% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -597.956% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -175.416% |
| Cellectis S.A. | -43.85 Million USD | -698.618% |
| Longeveron Inc. | -2.9 Million USD | -11943.81% |
| Repare Therapeutics Inc. | -107.85 Million USD | -224.718% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 136.167% |
| Inozyme Pharma, Inc. | 12 Million USD | 3017.644% |
| Revolution Medicines, Inc. | -608.2 Million USD | 42.415% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -28374.309% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -32.105% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -133.377% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -2138.346% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -47228.919% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.338% |
| Denali Therapeutics Inc. | -74.86 Million USD | -367.821% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2820.637% |
| Veru Inc. | 4.77 Million USD | 7427.119% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -3014.298% |
| Cingulate Inc. | 3.08 Million USD | 11461.337% |
| Passage Bio, Inc. | 4.58 Million USD | 7738.691% |
| Context Therapeutics Inc. | -14.44 Million USD | -2323.794% |
| Exicure, Inc. | 5.84 Million USD | 6087.93% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -52.027% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -785.1% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2332.069% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -495.423% |
| Nuvalent, Inc. | -335.38 Million USD | -4.427% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 20294.068% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -370.226% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3839.64% |
| OmniAb, Inc. | 9.2 Million USD | 3905.65% |
| Anew Medical, Inc. | 1.43 Million USD | 24549.742% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 2237.952% |
| Lipocine Inc. | -4.75 Million USD | -7266.226% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -218.893% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2399.481% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -591.356% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1507.014% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -5111.04% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -432.052% |
| Ocugen, Inc. | -32.52 Million USD | -976.947% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -309.271% |
| Q32 Bio Inc. | -37.94 Million USD | -822.931% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -55669.745% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2488.765% |
| Equillium, Inc. | -22.39 Million USD | -1464.103% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1269.814% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -973.456% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -141171.807% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 361.287% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 11051.657% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 106735.286% |
| Dominari Holdings Inc. | 195 Thousand USD | 179707.18% |
| Edesa Biotech, Inc. | -5.26 Million USD | -6549.705% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3827.711% |
| Bio-Techne Corporation | 267.74 Million USD | 230.808% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -2060.738% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -196.572% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -4067.964% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2668.429% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -42.883% |
| Nkarta, Inc. | 57.29 Million USD | 711.239% |
| BioCardia, Inc. | 212 Thousand USD | 165304.717% |
| Iterum Therapeutics plc | 13.43 Million USD | 2706.296% |